CYP11B1 | Cytochrome P450, family 11, subfamily B, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins
| | | | | Tissue enriched |
CYP11B2 | Cytochrome P450, family 11, subfamily B, polypeptide 2 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enriched |
HSD3B2 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enriched |
CYP21A2 | Cytochrome P450, family 21, subfamily A, polypeptide 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
SELM | Selenoprotein M | Predicted secreted proteins
| | | | | Tissue enriched |
TH | Tyrosine hydroxylase | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enriched |
NOV | Nephroblastoma overexpressed | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CAMK2N2 | Calcium/calmodulin-dependent protein kinase II inhibitor 2 | | | | | | Group enriched |
CYP17A1 | Cytochrome P450, family 17, subfamily A, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FAM166B | Family with sequence similarity 166, member B | | | | | | Group enriched |
TUBB4A | Tubulin, beta 4A class IVa | Disease related genes Plasma proteins
| | | | | Group enriched |
NSG2 | Neuron-specific protein family member 2 | Predicted membrane proteins
| | | | | Group enriched |
PNMT | Phenylethanolamine N-methyltransferase | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enriched |
CHGB | Chromogranin B (secretogranin 1) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FSTL5 | Follistatin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
DLK1 | Delta-like 1 homolog (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
INA | Internexin neuronal intermediate filament protein, alpha | | | | | | Group enriched |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
PPP1R17 | Protein phosphatase 1, regulatory subunit 17 | | | | | | Group enriched |
SYT14 | Synaptotagmin XIV | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
DBH | Dopamine beta-hydroxylase (dopamine beta-monooxygenase) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FDX1 | Ferredoxin 1 | Mitochondrial proteins
| | | | | Tissue enriched |
PENK | Proenkephalin | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
SYT4 | Synaptotagmin IV | | | | | | Group enriched |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enriched |
AS3MT | Arsenic (+3 oxidation state) methyltransferase | Enzymes
| | | | | Tissue enriched |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
MCOLN3 | Mucolipin 3 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
MYT1 | Myelin transcription factor 1 | Plasma proteins Transcription factors
| | | | | Group enriched |
RALYL | RALY RNA binding protein-like | | | | | | Group enriched |
RGN | Regucalcin | Enzymes Plasma proteins
| | | | | Group enriched |
FAIM2 | Fas apoptotic inhibitory molecule 2 | Predicted membrane proteins
| | | | | Group enriched |
NRIP3 | Nuclear receptor interacting protein 3 | | | | | | Group enriched |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
STAR | Steroidogenic acute regulatory protein | Disease related genes Mitochondrial proteins
| | | | | Tissue enriched |
SYNGR3 | Synaptogyrin 3 | Predicted membrane proteins
| | | | | Group enriched |
TMEM179 | Transmembrane protein 179 | Predicted membrane proteins
| | | | | Group enriched |
UCHL1 | Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
FAM43B | Family with sequence similarity 43, member B | | | | | | Tissue enriched |
LUZP2 | Leucine zipper protein 2 | Predicted secreted proteins
| | | | | Group enriched |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
RET | Ret proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
SHANK1 | SH3 and multiple ankyrin repeat domains 1 | Plasma proteins
| | | | | Group enriched |
SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | Plasma proteins RAS pathway related proteins
| | | | | Group enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO4 | Anoctamin 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |